Eris Lifesciences (BOM:540596) Ending Cash Position : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Ending Cash Position?

Eris Lifesciences's Ending Cash Position for the quarter that ended in Dec. 2023 was ₹0 Mil.

Eris Lifesciences's annual Ending Cash Position increased from Mar. 2021 (₹369 Mil) to Mar. 2022 (₹509 Mil) and increased from Mar. 2022 (₹509 Mil) to Mar. 2023 (₹560 Mil).

Eris Lifesciences Ending Cash Position Historical Data

The historical data trend for Eris Lifesciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Ending Cash Position Chart

Eris Lifesciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Ending Cash Position

Get a 7-Day Free Trial

75.00

673.07

369.15

508.70

560.22

Eris Lifesciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

Eris Lifesciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Eris Lifesciences's Ending Cash Position for the fiscal year that ended in Mar. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	583.6	+	-23.38
	=	560

Eris Lifesciences's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0

Eris Lifesciences Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Eris Lifesciences (BOM:540596) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » Ending Cash Position

Traded in Other Exchanges

ERIS:India

Address

Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054

Website

https://www.eris.co.in

Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (BOM:540596) Headlines

No Headlines